1 study found for:    20131302 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Advanced Chronic Myelogenous Leukemia (CML) - Follow On: Study of BMS-354825 in Subjects With CML
Conditions: Myeloid Leukemia, Chronic, Accelerated Phase;   Leukemia, Lymphoblastic, Acute, Philadelphia-Positive
Intervention: Drug: dasatinib

Indicates status has not been verified in more than two years